Development of immunoassays for burkholderia pseudomallei typical and atypical lipopolysaccharide strain typing

Teerapat Nualnoi, Michael H. Norris, Apichai Tuanyok, Paul J. Brett, Mary N. Burtnick, Paul S Keim, Erik W. Settles, Christopher J. Allender, David P. AuCoin

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Burkholderia pseudomallei is the causative agent of melioidosis, a severe infection endemic to many tropical regions. Lipopolysaccharide (LPS) is recognized as an important virulence factor used by B. pseudomallei. Isolates of B. pseudomallei have been shown to express one of four different types of LPS (typical LPS, atypical LPS types B and B2, and rough LPS) and in vitro studies have demonstrated that LPS types may impact disease severity. The association between LPS types and clinical manifestations, however, is still unknown, in part because an effective method for LPS type identification is not available. Thus, we developed antigen capture immunoassays capable of distinguishing between the LPS types. Mice were injected with B or B2 LPS for atypical LPS-specific monoclonal antibody (mAb) isolation; only two mAbs (3A2 and 5B4) were isolated from mice immunized with B2 LPS. Immunoblot analysis and surface plasmon resonance demonstrated that 3A2 and 5B4 are reactive with both B2 and B LPS where 3A2 was shown to possess higher affinity. Assays were then developed using capsular polysaccharide-specific mAb 4C4 for bacterial capture and 4C7 (previously shown to bind typical LPS) or 3A2 mAbs for typical or atypical LPS strain detection, respectively. The evaluations performed with 197 strains of Burkholderia and non-Burkholderia species showed that the assays are reactive to B. pseudomallei and Burkholderia mallei strains and have an accuracy of 98.8% (zero false positives and two false negatives) for LPS typing. The results suggest that the assays are effective and applicable for B. pseudomallei LPS typing.

Original languageEnglish (US)
Pages (from-to)358-367
Number of pages10
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume96
Issue number2
DOIs
StatePublished - 2017

Fingerprint

Burkholderia pseudomallei
Immunoassay
Lipopolysaccharides
Burkholderia mallei
Monoclonal Antibodies
Melioidosis
Burkholderia
Surface Plasmon Resonance
Virulence Factors

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases
  • Virology

Cite this

Development of immunoassays for burkholderia pseudomallei typical and atypical lipopolysaccharide strain typing. / Nualnoi, Teerapat; Norris, Michael H.; Tuanyok, Apichai; Brett, Paul J.; Burtnick, Mary N.; Keim, Paul S; Settles, Erik W.; Allender, Christopher J.; AuCoin, David P.

In: American Journal of Tropical Medicine and Hygiene, Vol. 96, No. 2, 2017, p. 358-367.

Research output: Contribution to journalArticle

Nualnoi, T, Norris, MH, Tuanyok, A, Brett, PJ, Burtnick, MN, Keim, PS, Settles, EW, Allender, CJ & AuCoin, DP 2017, 'Development of immunoassays for burkholderia pseudomallei typical and atypical lipopolysaccharide strain typing', American Journal of Tropical Medicine and Hygiene, vol. 96, no. 2, pp. 358-367. https://doi.org/10.4269/ajtmh.16-0308
Nualnoi, Teerapat ; Norris, Michael H. ; Tuanyok, Apichai ; Brett, Paul J. ; Burtnick, Mary N. ; Keim, Paul S ; Settles, Erik W. ; Allender, Christopher J. ; AuCoin, David P. / Development of immunoassays for burkholderia pseudomallei typical and atypical lipopolysaccharide strain typing. In: American Journal of Tropical Medicine and Hygiene. 2017 ; Vol. 96, No. 2. pp. 358-367.
@article{efa7edfdb5834c7ebc3d88a3a499c2e5,
title = "Development of immunoassays for burkholderia pseudomallei typical and atypical lipopolysaccharide strain typing",
abstract = "Burkholderia pseudomallei is the causative agent of melioidosis, a severe infection endemic to many tropical regions. Lipopolysaccharide (LPS) is recognized as an important virulence factor used by B. pseudomallei. Isolates of B. pseudomallei have been shown to express one of four different types of LPS (typical LPS, atypical LPS types B and B2, and rough LPS) and in vitro studies have demonstrated that LPS types may impact disease severity. The association between LPS types and clinical manifestations, however, is still unknown, in part because an effective method for LPS type identification is not available. Thus, we developed antigen capture immunoassays capable of distinguishing between the LPS types. Mice were injected with B or B2 LPS for atypical LPS-specific monoclonal antibody (mAb) isolation; only two mAbs (3A2 and 5B4) were isolated from mice immunized with B2 LPS. Immunoblot analysis and surface plasmon resonance demonstrated that 3A2 and 5B4 are reactive with both B2 and B LPS where 3A2 was shown to possess higher affinity. Assays were then developed using capsular polysaccharide-specific mAb 4C4 for bacterial capture and 4C7 (previously shown to bind typical LPS) or 3A2 mAbs for typical or atypical LPS strain detection, respectively. The evaluations performed with 197 strains of Burkholderia and non-Burkholderia species showed that the assays are reactive to B. pseudomallei and Burkholderia mallei strains and have an accuracy of 98.8{\%} (zero false positives and two false negatives) for LPS typing. The results suggest that the assays are effective and applicable for B. pseudomallei LPS typing.",
author = "Teerapat Nualnoi and Norris, {Michael H.} and Apichai Tuanyok and Brett, {Paul J.} and Burtnick, {Mary N.} and Keim, {Paul S} and Settles, {Erik W.} and Allender, {Christopher J.} and AuCoin, {David P.}",
year = "2017",
doi = "10.4269/ajtmh.16-0308",
language = "English (US)",
volume = "96",
pages = "358--367",
journal = "American Journal of Tropical Medicine and Hygiene",
issn = "0002-9637",
publisher = "American Society of Tropical Medicine and Hygiene",
number = "2",

}

TY - JOUR

T1 - Development of immunoassays for burkholderia pseudomallei typical and atypical lipopolysaccharide strain typing

AU - Nualnoi, Teerapat

AU - Norris, Michael H.

AU - Tuanyok, Apichai

AU - Brett, Paul J.

AU - Burtnick, Mary N.

AU - Keim, Paul S

AU - Settles, Erik W.

AU - Allender, Christopher J.

AU - AuCoin, David P.

PY - 2017

Y1 - 2017

N2 - Burkholderia pseudomallei is the causative agent of melioidosis, a severe infection endemic to many tropical regions. Lipopolysaccharide (LPS) is recognized as an important virulence factor used by B. pseudomallei. Isolates of B. pseudomallei have been shown to express one of four different types of LPS (typical LPS, atypical LPS types B and B2, and rough LPS) and in vitro studies have demonstrated that LPS types may impact disease severity. The association between LPS types and clinical manifestations, however, is still unknown, in part because an effective method for LPS type identification is not available. Thus, we developed antigen capture immunoassays capable of distinguishing between the LPS types. Mice were injected with B or B2 LPS for atypical LPS-specific monoclonal antibody (mAb) isolation; only two mAbs (3A2 and 5B4) were isolated from mice immunized with B2 LPS. Immunoblot analysis and surface plasmon resonance demonstrated that 3A2 and 5B4 are reactive with both B2 and B LPS where 3A2 was shown to possess higher affinity. Assays were then developed using capsular polysaccharide-specific mAb 4C4 for bacterial capture and 4C7 (previously shown to bind typical LPS) or 3A2 mAbs for typical or atypical LPS strain detection, respectively. The evaluations performed with 197 strains of Burkholderia and non-Burkholderia species showed that the assays are reactive to B. pseudomallei and Burkholderia mallei strains and have an accuracy of 98.8% (zero false positives and two false negatives) for LPS typing. The results suggest that the assays are effective and applicable for B. pseudomallei LPS typing.

AB - Burkholderia pseudomallei is the causative agent of melioidosis, a severe infection endemic to many tropical regions. Lipopolysaccharide (LPS) is recognized as an important virulence factor used by B. pseudomallei. Isolates of B. pseudomallei have been shown to express one of four different types of LPS (typical LPS, atypical LPS types B and B2, and rough LPS) and in vitro studies have demonstrated that LPS types may impact disease severity. The association between LPS types and clinical manifestations, however, is still unknown, in part because an effective method for LPS type identification is not available. Thus, we developed antigen capture immunoassays capable of distinguishing between the LPS types. Mice were injected with B or B2 LPS for atypical LPS-specific monoclonal antibody (mAb) isolation; only two mAbs (3A2 and 5B4) were isolated from mice immunized with B2 LPS. Immunoblot analysis and surface plasmon resonance demonstrated that 3A2 and 5B4 are reactive with both B2 and B LPS where 3A2 was shown to possess higher affinity. Assays were then developed using capsular polysaccharide-specific mAb 4C4 for bacterial capture and 4C7 (previously shown to bind typical LPS) or 3A2 mAbs for typical or atypical LPS strain detection, respectively. The evaluations performed with 197 strains of Burkholderia and non-Burkholderia species showed that the assays are reactive to B. pseudomallei and Burkholderia mallei strains and have an accuracy of 98.8% (zero false positives and two false negatives) for LPS typing. The results suggest that the assays are effective and applicable for B. pseudomallei LPS typing.

UR - http://www.scopus.com/inward/record.url?scp=85014575091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014575091&partnerID=8YFLogxK

U2 - 10.4269/ajtmh.16-0308

DO - 10.4269/ajtmh.16-0308

M3 - Article

C2 - 27994103

AN - SCOPUS:85014575091

VL - 96

SP - 358

EP - 367

JO - American Journal of Tropical Medicine and Hygiene

JF - American Journal of Tropical Medicine and Hygiene

SN - 0002-9637

IS - 2

ER -